nach oben

Medical Oncology

Erschienen in:

01.03.2008 | CASE

Breast cancer with an unusual leukemia-like presentation: case report and literature review

verfasst von: Yuan-Hsin Chang, Ruey-Kuen Hsieh, Ming-Chi Chang, Gon-Shen Chen

Erschienen in: Medical Oncology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the most common cancer in women in the world and the second-most common cancer in women in Taiwan. However, breast cancer with plentiful leukemia blast-like cells circulating in the peripheral blood is very rare. A 48-year-old woman with breast cancer and leukemia-like manifestations was admitted in August, 2006. Special staining and immunophenotyping studies to determine the origin of her peripheral blast cells confirmed that they were from her breast carcinoma. Carcinocythemia (carcinoma cell leukemia) was diagnosed and then systemic chemotherapy and hormone therapy were given. Nevertheless, she expired 9 months after carcinocythemia presentation. The differential diagnosis of this condition, which is complicated by chemotherapy or radiotherapy for solid tumors, is very important. Patients with carcinocythemia have poor prognosis and survival.

Carey RW, Taft PD, Bennett JM, Kaufman S. Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells. Am J Med 1976;60:273–8.PubMedCrossRef

Aboulafia DM. Carcinocythemia. A terminal manifestation of metastatic breast cancer. West J Med 1992;157:672–4.PubMed

Seronie-Vivien S, et al. Carcinocythemia as the single extension of breast cancer: report of a case and review of the literature. Ann Oncol 2001;12:1019–22.PubMedCrossRef

Rodriguez-Salas N, et al. Circulating cancer cells in peripheral blood. A case report. Acta Cytol 2000;44:237–41.PubMed

Boer K, Lang I, Juhos E, Pinter T, Szanto J. [Hungarian experience with docetaxel combination (TAC) in the adjuvant treatment of breast cancer. Results of BCIRG 001 randomized, multicentric, phase III trial]. Magy Onkol 2003;47:141–8.PubMed

Martin M, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005;352:2302–13.PubMedCrossRef

Lugassy G, et al. Carcinocythemia. Report of two cases, one simulating a Burkitt lymphoma. Acta Cytol 1990;34:265–8.PubMed

Ashworth TR. A case of cancer in which cells similar to those in the tumours where seen in the blood after death. Aust Med J 1869;14:146.

Gallivan MV, Lokich JJ. Carcinocythemia (carcinoma cell leukemia). Report of two cases with English literature review. Cancer 1984;53:1100–2.PubMedCrossRef

10.

Cristofanilli M, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781–91.PubMedCrossRef

11.

Funaki NO, et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997;25:564–8.PubMedCrossRef

12.

Medic S, Pearce RL, Heenan PJ, Ziman M. Molecular markers of circulating melanoma cells. Pigment Cell Res 2007;20:80–91.PubMedCrossRef

13.

Glumac N, Snoj M, Hocevar M, Novakovic S. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma. Neoplasma 2006;53:9–14.PubMed

14.

Song J, From P, Morrisey W, Sams J. Circulating cancer cells: Pre and post-chemotherapy observations. Cancer 1971;28:553–61.PubMedCrossRef

15.

Goddard MJ, Wilson B, Grant JW. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J Clin Pathol 1991;44:660–3.PubMedCrossRef

16.

To A, et al. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol 1981;34:1326–32.PubMedCrossRef

17.

Berois N, et al. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 1997;17:2639–46.PubMed

18.

Nasr F, et al. Carcinoma cell leukemia. Blood 1996;88:2355–57.PubMed

19.

Bonneterre J, et al. Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer. Br J Cancer 2004;91:1466–71.PubMed

20.

Ali R, et al. Small cell lung cancer presenting as acute leukaemia. Cytopathology 2005;16:262–3.PubMedCrossRef

21.

Pitini V, Arrigo C, Altavilla G. An acute-leukaemia-like picture due to breast carcinoma cells. Lancet Oncol 2006;7:524.PubMedCrossRef

22.

Tam CS, Turner P, McLean C, Whitehead S, Cole-Sinclair M. ‘Leukaemic’ presentation of metastatic Merkel cell carcinoma. Br J Haematol 2005;129:446.PubMedCrossRef

23.

Finkel GC, Tishkoff GH. Malignant cells in a peripheral blood smear: report of a case. N Engl J Med 1960;262:187–8.PubMedCrossRef

24.

Myerowitz RL, Edwards PA, Sartiano GP. Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: report of a case. Cancer 1977;40:3107–11.PubMedCrossRef

25.

Dannaher CL, Yam LT, McKeown JM. Metastatic carcinoma with carcinocythemia mimicking leukemia. South Med J 1979;72:622–4.PubMed

26.

Ejeckam GC, Sogbein SK, McLeish WA. Carcinocythemia due to metastatic oat-cell carcinoma of the lung. Can Med Assoc J 1979;120:336–8.PubMed

27.

Krause JR. Rhabdomyosarcoma presenting as carcinocythemia. South Med J 1979;72:1007–8.PubMed

28.

Solanki DL, McCurdy PR. Oat cell carcinoma mimicking leukemia. Postgrad Med 1980;68:213–6.PubMed

29.

Thompson PJ, Maloney P, Hewson J. Small-cell carcinocythaemia. Thorax 1982;37:770.PubMedCrossRef

30.

Yam LT, Janckila AJ. Immunocytodiagnosis of carcinocythemia in disseminated breast cancer. Acta Cytol 1987;31:68–72.PubMed

31.

Maldonado A, Fradera J, Velez-Garcia E. Carcinocythemia in a patient with rhabdomyosarcoma. Bol Asoc Med P R 1991;83:13–16.PubMed

32.

Sile CC, Perry DJ, Nam L. Small cell carcinocythemia. Arch Pathol Lab Med 1999;123:426–8.PubMed

Titel: Breast cancer with an unusual leukemia-like presentation: case report and literature review
verfasst von: Yuan-Hsin Chang
Ruey-Kuen Hsieh
Ming-Chi Chang
Gon-Shen Chen
Publikationsdatum: 01.03.2008
Verlag: Humana Press Inc
Erschienen in: Medical Oncology / Ausgabe 1/2008
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-007-0048-2

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Breast cancer with an unusual leukemia-like presentation: case report and literature review

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Mature results of neoadjuvant chemotherapy followed by radiotherapy in nasopharyngeal cancer: is it really old fashioned?

Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis

Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey

Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients

Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor

Cancer during pregnancy: 10-year experience at a regional cancer reference center in Mexico

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie